Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Anti-diabetic drug Stories

2012-02-07 14:51:17

In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere...

2012-02-06 08:00:00

The US Drug Watchdog says, "We totally underestimated the number of diabetics in the United States, who used the diabetes drug called Actos, and now have bladder cancer. We now believe the number of diabetics, who used the diabetes drug called Actos, and have now developed bladder cancer could easily be in the thousands. We want to get every possible victim identified to insure they have the most capable attorneys. We can't even imagine how you put a price on this mess, but its huge." There...

2012-01-31 05:30:00

SAN DIEGO, Jan. 31, 2012 /PRNewswire/ -- Profil(®) Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today the appointment of Dr. John Amatruda, a pharmaceutical research executive, and Dr. Jerrold Olefsky, professor of medicine at the University of California, San Diego, to its Board of Directors. "Drs. Amatruda and Olefsky are prominent and highly respected leaders both in the global bio-pharmaceutical industry...

2012-01-27 17:15:00

Type 2 diabetes is a common disorder in the United States, with over 8 percent of the general population or more than 20 million people affected by it. Additionally, over 40 million people in the US have a condition called pre-diabetes or impaired glucose tolerance, which can transform into full-blown diabetes over time (National Center for Chronic Disease Prevention and Health Promotion). (PRWEB) January 27, 2012 Type 2 diabetes is a common disorder in the United States, with over 8...

2012-01-20 19:50:00

Sucanon is a breakthrough herbal-based treatment of type 2 diabetes, which unlike traditionally used medication is not associated with side effects or harmful metabolic changes in the body. (PRWEB) January 20, 2012 Sucanon is a breakthrough herbal-based treatment of type 2 diabetes, which unlike traditionally used medication is not associated with side effects or harmful metabolic changes in the body. Although researchers were enthusiastic about Sucanon's ability to effectively address...

2012-01-18 08:00:00

The US Drug Watchdog says, "We think diabetics using the diabetes drug called Actos, who then developed bladder cancer may become one of our group's more important drug initiatives ever. We now need the help of loved ones, or family members of diabetics, who now have bladder cancer, to ask if the diabetic was, or has been using the drug called Actos. There appears to be a correlation between US diabetics, bladder cancer, and the drug called Actos, and we want to identify every possible...

2012-01-13 08:00:00

The US Drug Watchdog says, "We do not think the average bladder cancer victim, who is also a diabetic would ever consider a drug for diabetes could be a contributing factor for bladder cancer, so we are urging loved ones, or family members to ask the question-were you using Actos before being diagnosed with bladder cancer? There may be a elevated incidence of bladder cancer for users of the diabetes drug called Actos, and we want to identify every US victim, in the hopes we can get them some...

2012-01-10 16:50:00

Sucanon announces a new diabetes treatment that works in a natural manner by increasing the sensitivity of body tissues to circulating insulin and providing relief of unpleasant diabetes symptoms that decrease the patient's quality of life and productivity. (PRWEB) January 10, 2012 Sucanon announces a new diabetes treatment that works in a natural manner by increasing the sensitivity of body tissues to circulating insulin and providing relief of unpleasant diabetes symptoms that decrease...

2012-01-10 23:40:04

New findings could influence design of future diabetes treatments Using a blend of technologies, scientists from the Florida campus of The Scripps Research Institute have painted a new picture of how biochemical information can be transmitted through the modification of a protein. Previously, scientists believed that during the pairing of proteins and their binding partners ("ligands"), proteins modified their shape while ligands remained stable. The new study shows this one-size-fits-all...

2012-01-05 17:10:00

The clinical benefits of Sucanon were convincingly demonstrated in a double-blind, randomized, placebo- & Glibenclamide controlled, multi-center, efficacy and safety study in 370 adult patients with Type II diabetes. (PRWEB) January 05, 2012 The clinical benefits of Sucanon were convincingly demonstrated in a double-blind, randomized, placebo- & Glibenclamide controlled, multi-center, efficacy and safety study in 370 adult patients with Type II diabetes. The trials have shown that...